3rd Quarter - Report

PARENT PROJECT MUSCULAR DYSTROPHY for PARENT PROJECT MUSCULAR DYSTROPHY

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures/Biomedical Innovations; PDUFA VI; Appropriations Bill/Report Language

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: Social Security Administration (SSA); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); SENATE; Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Defense DEF

Congressionally Directed Medical Research Programs

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; Social Security Administration (SSA); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Appropriations

LobbyistCovered position, as disclosed
ANNIE KENNEDY —

Contacted: Defense, Dept of (DOD); Social Security Administration (SSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.